Onconetix (ONCO) Stock Surges Over 23% Overnight: Why Is It Moving?

Onconetix Inc. (NASDAQ:ONCO) shares surged 23.65% to $0.38 in after-hours trading on Monday, reversing an 18.26% regular session decline. The biotech company reported clinical validation progress for Proclarix, a blood test for prostate cancer detection, with new peer-reviewed publications and initiation of a U.S. validation trial with Labcorp. However, the stock has dropped 99.11% over the past 12 months and currently trades at its annual low.

05/19/2026, 3:03 AM • Benzinga

Labcorp Advances As AI Investments, Core Businesses Drive Growth

Labcorp Holdings (LH) shares rose 1.46% after reporting strong Q1 results with adjusted EPS of $4.25 beating consensus of $4.09, and sales of $3.54 billion exceeding expectations. The company raised full-year 2026 adjusted EPS guidance to $18.03 at midpoint, driven by momentum in Diagnostics and Central Laboratory businesses, along with investments in AI and robotics technologies.

04/30/2026, 12:05 PM • Benzinga

Drug Development Services Market Research Report 2026: $50+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

The drug development services market is projected to grow from $28.09 billion in 2025 to $50.26 billion by 2030 at a CAGR of 12.4%, driven by increased R&D investments, AI adoption, personalized medicine, and emerging market expansion. Key growth areas include preclinical research, regulatory optimization, and cloud-based data management, with precision medicine and genomics advancements playing pivotal roles.

04/14/2026, 10:59 AM • GlobeNewswire

Labcorp Declares Quarterly Dividend

Labcorp Holdings Inc. (NYSE:LH) announced that its Board of Directors has declared a cash dividend of $0.72 per share of common stock, payable on June 11, 2026, to stockholders of record as of May 29, 2026.

04/09/2026, 6:50 AM • Benzinga

Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor Intelligence

The global drug screening market is projected to reach USD 20.86 billion by 2031, growing at a CAGR of 16.16%. Chromatography and mass spectrometry technologies dominated with 44.77% market share in 2025. Asia-Pacific is the fastest-growing region, driven by expanding healthcare infrastructure and workplace safety initiatives. Market growth is fueled by increasing adoption across workplaces, healthcare settings, and law enforcement, alongside technological advancements in point-of-care testing and rapid detection devices.

04/03/2026, 3:15 AM • GlobeNewswire

Genomics Services Market Projected to Surpass USD 25.18 Billion by 2035; Increasing Genetic Disorders’ Prevalence is Driving Market Growth Globally – SNS Insider

The global genomics services market is expected to grow from USD 7.94 billion in 2025 to USD 25.18 billion by 2035, with a CAGR of 11.8%. Growth is driven by increasing genetic disorder prevalence, government-funded precision medicine initiatives, and rising adoption of NGS-based diagnostics. The U.S. market alone is projected to reach USD 10.04 billion by 2035. Next-generation sequencing dominates with 38.42% market share, while Asia Pacific shows the fastest growth at 13.84% CAGR.

03/05/2026, 4:36 AM • GlobeNewswire

OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - Privacy, Digital Access, and Rapid Results Accelerate Adoption

A comprehensive market research report on over-the-counter and direct-to-consumer infectious disease diagnostics forecasts significant growth through 2029, driven by rapid testing technologies, privacy concerns, and digital accessibility. The report analyzes market trends across 15 countries, covering respiratory, STD, UTI, and other infectious disease testing channels, with profiles of 70+ diagnostic companies.

02/03/2026, 8:00 AM • GlobeNewswire

Esoteric Testing Research Report 2026 - Global $41.5+ Bn Market Trends, Opportunities, and Forecasts to 2031

The global esoteric testing market is projected to grow from $27.52 billion in 2025 to $41.56 billion by 2031 at a 7.11% CAGR, driven by rising chronic disease rates, personalized medicine demand, and liquid biopsy adoption. However, stringent regulatory frameworks and reimbursement pressures pose significant challenges to market expansion.

01/30/2026, 4:57 AM • GlobeNewswire

Labcorp Declares Quarterly Dividend

Labcorp Holdings Inc. (NYSE:LH) announced a quarterly cash dividend of $0.72 per share, payable on March 12, 2026, to shareholders of record as of February 27, 2026. The company is a global leader in laboratory services with nearly 70,000 employees serving clients in approximately 100 countries.

01/14/2026, 6:50 AM • Benzinga

Best Testosterone Replacement Therapy (TRT) 2026: Taurus Meds Consumer Analysis Examines Online TRT Access and At-Home Testosterone Treatment Options

A consumer analysis examines how Taurus Medical, Inc. operates its telehealth TRT platform, which connects patients with licensed healthcare providers through OpenLoop Healthcare Partners. The analysis details the regulatory framework for testosterone as a Schedule III controlled substance, the three-entity operational structure (platform, providers, pharmacies), laboratory testing partnerships with LabCorp and Quest Diagnostics, and treatment options including injectable testosterone and enclomiphene. The article emphasizes that no prescription is guaranteed and that clinical decisions rest solely with independent licensed clinicians.

01/12/2026, 7:02 PM • GlobeNewswire

$43.36 Bn Autism Spectrum Disorder Diagnostics Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F

The global autism spectrum disorder diagnostics market is projected to grow from $27.38 billion in 2024 to $43.36 billion by 2034, with a CAGR of 4.7%. Key growth drivers include increasing healthcare expenditure, R&D investments, and government initiatives. The autistic disorder segment will dominate at 52.82% market share, while early intervention services and online pharmacies emerge as fastest-growing segments. Major players include LabCorp, Illumina, and Bio-Rad Laboratories, with Asia Pacific and Western Europe expected to lead regional growth.

01/08/2026, 4:51 AM • GlobeNewswire

Bioanalytical Services Market Projected to Reach US$ 11.61 Billion by 2035, Driven by Rising FDA Approvals and Clinical Trial Activity Says Astute Analytica

The global bioanalytical services market is expected to grow from US$ 3.96 billion in 2025 to US$ 11.61 billion by 2035 at a CAGR of 11.6%. Growth is driven by FDA Modernization Act 2.0 implementation, increased clinical trial activity, and a shift toward advanced testing methodologies like cell-based assays and LC-MS/MS platforms. Cell-based assays lead with 46.1% market share, while small molecules account for 55.4%. Oncology applications dominate at 32% share, driven by the explosive pipeline of 1,200+ Antibody-Drug Conjugates.

01/05/2026, 1:00 PM • GlobeNewswire

Reproductive Genetics Market Size to Reach USD 16.67 Billion in 2032 Amid Increasing Demand for Genetic Testing

The global reproductive genetics market is projected to grow from USD 7.31 billion in 2025 to USD 16.67 billion by 2032, with a CAGR of 12.5%. Growth is driven by rising demand for genetic testing, preimplantation genetic testing (PGT), and non-invasive prenatal testing (NIPT), though ethical and legal challenges continue to limit expansion. North America leads with 40.5% market share, while Asia Pacific is the fastest-growing region.

12/30/2025, 10:00 AM • GlobeNewswire

$3.5 Bn Cell and Gene Therapy CRO Market Industry Trends and Global Forecasts to 2035 Cell Therapy, Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions

The global cell and gene therapy Contract Research Organization (CRO) market is projected to grow from $1.7 billion in 2025 to $3.5 billion by 2035, driven by FDA-approved therapies and increasing clinical trials across multiple therapeutic areas.

12/05/2025, 4:16 AM • GlobeNewswire

Fertility Test Market Report 2025-2033, with Profiles of Quest Diagnostics, Mayo Clinic Laboratories, Ovation Fertility, Illume Fertility, Proov, BioMerieux, Labcorp, CCRM Fertility, and Maven Clinic

Global fertility test market projected to grow from $7.92 billion in 2025 to $14.74 billion in 2033, driven by lifestyle changes, delayed pregnancies, and increasing infertility rates worldwide.

10/21/2025, 10:00 AM • GlobeNewswire